These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 36158238)

  • 41. [Effect of 2-phenylethyl-beta-glucopyranoside isolated from Huaizhong No. 1 Rehmannia glutinosa on hypoxic pulmonary hypertension by regulating PI3K/Akt/m TOR/HIF-1α pathway].
    Zeng MN; Zhang YH; Guo PL; Zhang ZY; Liu YL; Wang R; Tie QM; Wang YY; Chang FZ; Feng WS; Zheng XK
    Zhongguo Zhong Yao Za Zhi; 2024 Jul; 49(14):3857-3867. PubMed ID: 39099359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The hypoxia-inducible factor 1 inhibitor LW6 mediates the HIF-1α/PD-L1 axis and suppresses tumor growth of hepatocellular carcinoma in vitro and in vivo.
    Xu H; Chen Y; Li Z; Zhang H; Liu J; Han J
    Eur J Pharmacol; 2022 Sep; 930():175154. PubMed ID: 35868447
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypoxia promotes the migration and invasion of human hepatocarcinoma cells through the HIF-1α-IL-8-Akt axis.
    Fei M; Guan J; Xue T; Qin L; Tang C; Cui G; Wang Y; Gong H; Feng W
    Cell Mol Biol Lett; 2018; 23():46. PubMed ID: 30258464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ovatodiolide and antrocin synergistically inhibit the stemness and metastatic potential of hepatocellular carcinoma via impairing ribosome biogenesis and modulating ERK/Akt-mTOR signaling axis.
    Chen MY; Hsu CH; Setiawan SA; Tzeng DTW; Ma HP; Ong JR; Chu YC; Hsieh MS; Wu ATH; Tzeng YM; Yeh CT
    Phytomedicine; 2023 Jan; 108():154478. PubMed ID: 36265255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Canagliflozin Modulates Hypoxia-Induced Metastasis, Angiogenesis and Glycolysis by Decreasing HIF-1α Protein Synthesis via AKT/mTOR Pathway.
    Luo J; Sun P; Zhang X; Lin G; Xin Q; Niu Y; Chen Y; Xu N; Zhang Y; Xie W
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway.
    Xu R; Zhang Y; Li A; Ma Y; Cai W; Song L; Xie Y; Zhou S; Cao W; Tang X
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Local anesthetic bupivacaine inhibits proliferation and metastasis of hepatocellular carcinoma cells via suppressing PI3K/Akt and MAPK signaling.
    Wang L; Guo W; Guan H; Yan N; Cai X; Zhu L
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22871. PubMed ID: 34338398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypoxia-induced UBE2K promotes the malignant progression of HCC.
    Ouyang G; Fu W; Guo J; Lu Q; Yao Y; Ge L; Zhao J; Zhang J; Hu X; Li S; Xu Q; Huang D; Zhang Y
    Pathol Res Pract; 2023 May; 245():154422. PubMed ID: 37003132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Periostin contributes to arsenic trioxide resistance in hepatocellular carcinoma cells under hypoxia.
    Liu Y; Gao F; Song W
    Biomed Pharmacother; 2017 Apr; 88():342-348. PubMed ID: 28119236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells.
    Grabinski N; Ewald F; Hofmann BT; Staufer K; Schumacher U; Nashan B; Jücker M
    Mol Cancer; 2012 Nov; 11():85. PubMed ID: 23167739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Krüppel-like factor 8 regulates VEGFA expression and angiogenesis in hepatocellular carcinoma.
    Cheng S; Zhang X; Xu Y; Dai X; Li J; Zhang T; Chen X
    Sci Rep; 2018 Nov; 8(1):17415. PubMed ID: 30479372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma.
    Zhou LJ; Mo YB; Bu X; Wang JJ; Bai J; Zhang JW; Cheng AB; Ma JH; Wang YW; Xie YX
    Cell Physiol Biochem; 2018; 50(3):851-867. PubMed ID: 30355923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypoxic Hepatocellular Carcinoma Cells Acquire Arsenic Trioxide Resistance by Upregulating HIF-1α Expression.
    Chen Y; Li H; Chen D; Jiang X; Wang W; Li D; Shan H
    Dig Dis Sci; 2022 Aug; 67(8):3806-3816. PubMed ID: 34383201
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells.
    Sun YZ; Cai N; Liu NN
    Cell Physiol Biochem; 2017; 44(4):1640-1650. PubMed ID: 29216640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells.
    Zhang Q; Tang X; Lu QY; Zhang ZF; Brown J; Le AD
    Mol Cancer Ther; 2005 Oct; 4(10):1465-74. PubMed ID: 16227395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Catalpol synergistically potentiates the anti-tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB and VEGF/VEGFR2 signaling pathways.
    El-Hanboshy SM; Helmy MW; Abd-Alhaseeb MM
    Mol Biol Rep; 2021 Nov; 48(11):7233-7242. PubMed ID: 34596810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis.
    Feng J; Dai W; Mao Y; Wu L; Li J; Chen K; Yu Q; Kong R; Li S; Zhang J; Ji J; Wu J; Mo W; Xu X; Guo C
    J Exp Clin Cancer Res; 2020 Jan; 39(1):24. PubMed ID: 32000827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ruscogenin suppressed the hepatocellular carcinoma metastasis via PI3K/Akt/mTOR signaling pathway.
    Hua H; Zhu Y; Song YH
    Biomed Pharmacother; 2018 May; 101():115-122. PubMed ID: 29477471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.